skip to Main Content

VCU’s New Pancreatic Cancer Treatment Could Improve Outcomes

Newsfeed image, light gray text on dark gray background
The outlook for a pancreatic cancer patient is usually dismal. The five-year survival rate for those with stage IV cancer — indicating the most advanced diagnosis — is only about 1 percent.

Even for those diagnosed at stage I, the five-year survival rate is still only between 12 and 14 percent.

That’s why Dr. Emma Fields, a radiation oncologist with VCU Massey Cancer Center, thought the CivaSheet — approved by the U.S. Food and Drug Administration in 2014 — might offer some hope to those patients. Read more . . .

Back To Top